Clinical Trial

EVALUATION OF NEUTROPHIL FLUORESCENCE IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCK

Study acronym: HEMATOCLOT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Neutrophil fluorescence could be a reliable and early diagnostic marker of disseminated intravascular coagulation septic DIC, which can be used routinely. The objective of the investigators is to define the optimal threshold of neutrophil fluorescence associated with a sensitivity of at least 90% for the diagnosis of DIC.
Trial Details
NCT Number NCT07039487
Lead Sponsor University Hospital, Strasbourg, France
Conditions DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCK
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-26